Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Darley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Experimental Hematology|November 24, 1999
Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursorsR L Darley, A K Burnett
Cancer Immunology, Immunotherapy : CII|November 1, 1993
Sequential changes in MHC antigen expression induced by the v-Ki-ras oncogeneR L Darley, A G Morris
Haematologica|March 1, 1997
The molecular basis of myelodysplastic syndromesA Gallagher, R L Darley, R Padua
Cancer Immunology, Immunotherapy : CII|January 1, 1992
The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cellsA G Morris, R L Darley, W J Bateman
Leukemia Research|July 1, 1997
Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cellsF Zaker, R L Darley, A al Sabah, et al.
Cancer Research|May 15, 1998
Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent processA P Gallagher, A K Burnett, D T Bowen, et al.
Leukemia Research|January 14, 2000
Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cellsA P McGlynn, R A Padua, A K Burnett, et al.
Oncogene|December 22, 2009
OGG1 is a novel prognostic indicator in acute myeloid leukaemiaK Liddiard, R Hills, A K Burnett, et al.
Leukemia Research|April 1, 1995
Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPAK Kuliczkowski, R L Darley, A Jacobs, et al.
The Journal of Experimental Medicine|April 7, 1997
Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cellsR L Darley, T G Hoy, P Baines, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Experimental Hematology|November 24, 1999
Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursorsR L Darley, A K Burnett
Cancer Immunology, Immunotherapy : CII|November 1, 1993
Sequential changes in MHC antigen expression induced by the v-Ki-ras oncogeneR L Darley, A G Morris
Haematologica|March 1, 1997
The molecular basis of myelodysplastic syndromesA Gallagher, R L Darley, R Padua
Cancer Immunology, Immunotherapy : CII|January 1, 1992
The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cellsA G Morris, R L Darley, W J Bateman
Leukemia Research|July 1, 1997
Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cellsF Zaker, R L Darley, A al Sabah, et al.
Cancer Research|May 15, 1998
Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent processA P Gallagher, A K Burnett, D T Bowen, et al.
Leukemia Research|January 14, 2000
Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cellsA P McGlynn, R A Padua, A K Burnett, et al.
Oncogene|December 22, 2009
OGG1 is a novel prognostic indicator in acute myeloid leukaemiaK Liddiard, R Hills, A K Burnett, et al.
Leukemia Research|April 1, 1995
Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPAK Kuliczkowski, R L Darley, A Jacobs, et al.
The Journal of Experimental Medicine|April 7, 1997
Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cellsR L Darley, T G Hoy, P Baines, et al.
Pageof 2